Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

143.89
Delayed Data
As of Sep 22
 +0.11 / +0.08%
Today’s Change
96.93
Today|||52-Week Range
144.59
+24.31%
Year-to-Date

Today’s Trading

Previous close143.78
Today’s open143.31
Day’s range141.75 - 144.19
Volume3,549,466
Average volume (3 months)3,780,447
Market cap$112.5B
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+23.16%
Earnings growth (next 5 years)+20.42%
Revenue growth (last year)+22.70%
P/E ratio44.7
Price/Sales8.51
Price/Book16.96

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.03+0.05%
GSKGlaxoSmithKline+0.25+0.62%
ABBVAbbVie+0.07+0.08%
SNYSanofi+0.39+0.78%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.88
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts